1. Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19
- Author
-
Özhan Özcan, İlkin Çankayalı, Ajda Turhan, Mehmet Sezai Taşbakan, Hüseyin Aytaç Erdem, Pervin Korkmaz, Kubilay Demirağ, Mehmet Uyar, Tansu Yamazhan, and Yeşim Aydınok
- Subjects
severe/critical covid-19 ,intensive care unit ,convalescent plasma ,the power of the igg ratio ,sofa score ,the apache ii score ,macrophage activation syndrome ,Medicine ,Internal medicine ,RC31-1245 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Objective: Relevant studies have suggested that the administration of convalescent plasma (CP) collected from COVID-19 patients who have recovered from the infection and whose plasma contains antibodies against SARS-CoV-2 is safe and may be effective in treating COVID-19 patients. The present study aimed to investigate whether the number of CP doses administered, the power of the IgG ratio and the time of CP administration following positive SARS-CoV-2 PCR had an impact on the 30-day in-hospital mortality. Materials and Methods: This single-center retrospective study was conducted with patients who were hospitalized and met the severe/critical COVID-19 disease criteria and received CP. Demographics, comorbidities, co-medications, onset of symptoms, duration between SARSCoV- 2 PCR testing and hospitalization, the time of the first CP administration, laboratory results, respiratory support needs, O2 saturation, fever at the baseline, APACHE II scores and SOFA scores were recorded. Results: Of the 224 patients with the mean age of 64.2±14.5 (19-91) years, 143 were male. The most common comorbidities were hypertension and congestive heart failure. Chronic renal failure, mechanical ventilation needs, PO2/FiO2
- Published
- 2024
- Full Text
- View/download PDF